Elsevier

The Lancet

Volume 364, Issue 9433, 7 August 2004, Pages 529-531
The Lancet

Fast track — Research Letters
Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood

https://doi.org/10.1016/S0140-6736(04)16812-8Get rights and content

Summary

In 1999, the UK implemented universal leucoreduction as a precaution against transmission of variant Creutzfeldt-Jakob disease by transfusion of domestic blood or red blood cells. We aimed to assess how effectively leucoreduction reduced infectivity of transmissible spongiform encephalopathies (TSEs) in blood. 450 mL of whole blood collected and pooled from scrapie-infected hamsters was leucoreduced with a commercial filter. Blood cell concentrations were quantified, and infectivity titres measured. Blood cell recovery and white blood cell removal complied with American Association of Blood Banks standards. Leucofiltration removed 42% (SD 12) of the total TSE infectivity in endogenously infected blood. Leucoreduction is necessary for the removal of white-cell-associated TSE infectivity from blood; however, it is not, by itself, sufficient to remove all blood-borne TSE infectivity.

References (7)

There are more references available in the full text version of this article.

Cited by (179)

View all citing articles on Scopus
View full text